Table 7.
Analysis of secondary outcome: TDW Re-epithelialization.
| 26–50% | 51–75% | 76–99% | 100% | Sum | |
|---|---|---|---|---|---|
| Skin graft re-epithelialization (TDW) (ITT, n=76 documented cases) | |||||
| EPO - no. (%) | 4 (10%) | 7 (17%) | 17 (43%) | 12 (30%) | 40 |
| Placebo - no. (%) | 2 (6%) | 4 (11%) | 13 (36%) | 17 (47%) | 36 |
| Sum - no. (%) | 6 (8%) | 11 (14%) | 30 (40%) | 29 (38%) | 76 |
ITT population data are presented as absolute numbers and in %.